StockNews.AI

AGL SHAREHOLDER ALERT: Securities Fraud Lawsuit Filed on Behalf of agilon health, inc. Investors - Contact Kirby McInerney LLP by March 2, 2026

StockNews.AI • 11 hours

AGL
High Materiality8/10

Information

NEW YORK, Jan. 20, 2026 (GLOBE NEWSWIRE) -- Kirby McInerney LLP reminds investors who purchased agil...

Original source

AI Summary

Agilon Health (AGL) is facing a securities fraud class action lawsuit after allegations of misleading financial guidance for 2025. The suspension of guidance and leadership changes have resulted in significant share price declines, suggesting ongoing investor concern and uncertainty about the company's future.

Sentiment Rationale

Legal issues historically lead to declining stock prices, especially in class action cases. AGL already experienced a steep price drop due to these revelations, supported by similar past scenarios affecting other firms.

Trading Thesis

Consider AGL as a short position given current legal and operational uncertainties in the next 3-6 months.

Market-Moving

  • Lawsuit outcome could further impact AGL's share price volatility.
  • Continued negative news on leadership transitions may deter investor confidence.
  • Potential settlements could lead to financial strains on AGL's operations.
  • Suspension of 2025 guidance raises concerns about revenue forecasts.

Key Facts

  • AGL faces a securities fraud class action lawsuit.
  • Investors claim AGL issued misleading financial guidance for 2025.
  • A leadership change occurred with the CEO's termination without cause.
  • AGL suspended its 2025 financial guidance amid industry headwinds.
  • AGL shares plummeted over 51% after guidance suspension announcement.

Companies Mentioned

  • Kirby McInerney LLP (N/A): Law firm representing shareholders in class action lawsuit against AGL.
  • Agilon Health, Inc. (AGL): Facing significant legal challenges and share price volatility.

Legal

This article falls under 'Legal' as it primarily discusses the ongoing class action lawsuit against Agilon Health, which could have significant implications on the company's stability and investor sentiment.

AGL Shareholder Alert: Securities Fraud Lawsuit Filed on Behalf of Agilon Health, Inc. Investors

NEW YORK, Jan. 20, 2026 (GLOBE NEWSWIRE) — Kirby McInerney LLP has notified investors of Agilon Health, Inc. (NYSE: AGL) regarding a securities fraud class action lawsuit. Investors who acquired AGL securities are urged to contact Lauren Molinaro of Kirby McInerney LLP at investigations@kmllp.com or by filling out the contact form to discuss their rights concerning this lawsuit at no cost. Those who have suffered financial losses from their investments in Agilon have until March 2, 2026, to apply for lead plaintiff status. It is critical to act before this deadline, as courts do not consider late applications.

Key Information on the Class Action Lawsuit

The lawsuit pertains to investors who purchased AGL securities during the class period from February 26, 2025, to August 4, 2025. Allegations against Agilon include:

  • Issuing guidance for 2025 that the Company knew or should have known was unattainable due to significant industry challenges.
  • Materially overstating the positive financial impact from strategic actions aimed at risk reduction.

Recent Events Impacting Agilon Health

On August 4, 2025, Agilon issued announcements regarding significant leadership changes, indicating that Steven Sell resigned as the President, CEO, and Director of the Board. This information came alongside a current report filed with the SEC, stating that his departure was classified as a termination without 'cause' under his employment agreement.

Additionally, Agilon's Executive Chair noted that as challenges increased throughout the transition year, the firm was suspending its previously issued financial guidance for 2025. Following this announcement, AGL shares plummeted by $0.94, translating to a 51.6% drop from $1.82 on August 4, 2025, to $0.88 on August 5, 2025.

Steps for Affected Investors

Investors who acquired AGL securities or possess relevant information about this case are encouraged to reach out to Lauren Molinaro at Kirby McInerney LLP to review their rights at no cost. Prompt action is essential to understand your options fully.

About Kirby McInerney LLP

Kirby McInerney LLP is a New York-based plaintiffs' law firm specializing in securities, antitrust, whistleblower, and consumer litigation. The firm's dedication to its clients in securities litigation has yielded billions in recovery for shareholders. For more details on the firm, visit their website.

Disclaimer: This announcement may be classified as Attorney Advertising in certain jurisdictions under applicable laws and ethical regulations.

Contact Information

For inquiries, please contact:

Kirby McInerney LLP

Lauren Molinaro, Esq.

Phone: 212-699-1171

Email: investigations@kmllp.com

Visit Our Website

Related News